School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Bipolar Disord. 2022 Jun;24(4):392-399. doi: 10.1111/bdi.13136. Epub 2021 Oct 7.
While clinical guidelines exist for the management of bipolar disorder (BD), there are significant challenges to their widespread dissemination and implementation in clinical practice. The Canadian Network of Mood and Anxiety Treatment Improving Patient Care and Outcomes in the Treatment of Bipolar Disorder (C-IMPACT BD) web-based application was developed for use at the point-of-care to improve adherence to guidelines for evidence-based pharmacological management of BD.
C-IMPACT BD uses a point-of-care practice assessment which, via adaptive questioning of patient-specific information, text/video descriptions of the guidelines, and pop-up prompts delivers personalized, evidence-based treatment recommendations for patients with BD. In order to inform quality improvement of the newly developed tool, a sample of Canadian physicians were invited to use the application and record its influence on their prescribing behavior.
Of 375 patients with bipolar I (BD-I) or bipolar II (BD-II) disorder for whom a point-of-care practice assessment was completed, a change in therapy was considered for 225 (60.0%). Prior to completing the assessment, 59.6% of these patients were receiving first-line therapy recommended for their phase of illness. Following the assessment, the overall number of patients for whom a first-line recommended therapy was being considered increased significantly to 76.9% (p = 0.0001).
Outcomes suggest that the C-IMPACT BD web-based application has the potential to improve physician adherence to clinical treatment guidelines. Formal research investigations are warranted to explore the impact of this tool on physician prescribing behavior and patient outcomes.
尽管存在针对双相情感障碍(BD)管理的临床指南,但在临床实践中广泛传播和实施这些指南仍存在重大挑战。加拿大情绪和焦虑治疗网络(C-IMPACT BD)是一个基于网络的应用程序,旨在改善 BD 的循证药物管理的指南遵守情况,以便在治疗点使用。
C-IMPACT BD 使用一种治疗点实践评估,通过对患者特定信息的适应性提问、指南的文本/视频描述以及弹出提示,为 BD 患者提供个性化的循证治疗建议。为了为新开发的工具提供质量改进信息,邀请了一些加拿大医生使用该应用程序,并记录其对他们的处方行为的影响。
在完成治疗点实践评估的 375 名双相 I(BD-I)或双相 II(BD-II)障碍患者中,有 225 名(60.0%)考虑改变治疗方法。在完成评估之前,这些患者中有 59.6%正在接受针对其疾病阶段推荐的一线治疗。评估后,考虑使用一线推荐治疗的患者总数显著增加到 76.9%(p=0.0001)。
结果表明,C-IMPACT BD 基于网络的应用程序有可能提高医生对临床治疗指南的遵守程度。需要进行正式的研究调查,以探讨该工具对医生处方行为和患者结局的影响。